| Literature DB >> 12620270 |
Marie-Christine Jacob1, Olivier Manches, Philippe Drillat, Marie-Jeanne Richard, Joël Plumas, Laurence Chaperot, Harald Hegelhofer, Frédéric Garban, Rémy Gressin, Marie Favrot, Jean-Claude Bensa, Martine Pernollet.
Abstract
In agreement with good practices for therapeutic use of human cells, quality control has to be performed to valid the process of extracorporeal photopheresis (ECP) with the Vilbert-Lourmat system. Since no protocol exists, we evaluated a technique based on the measurement of the inhibition of mitogen (PHA, Con-A, OKT3)-induced proliferation, in 164 procedures from 16 patients. Whatever the pathology, we observed a high proliferation rate in most samples, and we obtained over 90% ECP-induced inhibition in as many as 94% of the cases. Since this approach proved to be relevant regarding our objective, a protocol for the ECP process validation is proposed. Copyright 2003 Elsevier Science Ltd.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12620270 DOI: 10.1016/S1473-0502(02)00101-5
Source DB: PubMed Journal: Transfus Apher Sci ISSN: 1473-0502 Impact factor: 1.764